[Management of Acute Coronary Syndrome Without ST-segment Elevation]

Overview

Journal Herz

Specialty Cardiology & Vascular Diseases

Date 2017 Feb 25

PMID 28233037

Authors

C Liebetrau

C W Hamm

Affiliations

Soon will be listed here.

Abstract

Acute coronary syndrome without persistent ST-segment elevation (non-ST segment elevation myocardial infarction and instable angina pectoris NSTEMI-ACS) is common and is associated with a high mortality. In addition to 12-channel echocardiograph (ECG) assessment, measurement of cardiac troponins I and T are important for risk stratification and diagnosis. The introduction of high-sensitivity cardiac troponin assays and their implementation into clinical practice has influenced risk stratification and treatment of these patients. Additional diagnostic validation must supplement routine clinical chemistry testing following the initial measurement to distinguish between different possible causes of troponin elevation above the 99th percentile. The time point for the additional troponin measurement depends on the different protocols and troponin assays and is stipulated in the current guidelines. The use of both 1‑hour and 3‑hour protocols together with the clinical presentation and work-up of possible differential diagnoses provide optimal care of patients. Patients who test positive for troponin dynamics should undergo invasive diagnostics and treatment within 24 h of presentation and within 2 h is recommended for unstable patients. Clopidogrel is indicated only in patients requiring oral anticoagulation.

References

Dans A, Connolly S, Wallentin L, Yang S, Nakamya J, Brueckmann M . Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial. Circulation. 2012; 127(5):634-40. DOI: 10.1161/CIRCULATIONAHA.112.115386. View

Bonaca M, Bhatt D, Cohen M, Steg P, Storey R, Jensen E . Long-term use of ticagrelor in patients with prior myocardial infarction. N Engl J Med. 2015; 372(19):1791-800. DOI: 10.1056/NEJMoa1500857. View

Mockel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K . Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J. 2014; 36(6):369-76. PMC: 4320319. DOI: 10.1093/eurheartj/ehu178. View

Montalescot G, Bolognese L, Dudek D, Goldstein P, Hamm C, Tanguay J . Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromes. N Engl J Med. 2013; 369(11):999-1010. DOI: 10.1056/NEJMoa1308075. View

Neumann J, Sorensen N, Schwemer T, Ojeda F, Bourry R, Sciacca V . Diagnosis of Myocardial Infarction Using a High-Sensitivity Troponin I 1-Hour Algorithm. JAMA Cardiol. 2016; 1(4):397-404. DOI: 10.1001/jamacardio.2016.0695. View

Freimark D, Matetzky S, Leor J, Boyko V, Barbash I, Behar S . Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis. Am J Cardiol. 2002; 89(4):381-5. DOI: 10.1016/s0002-9149(01)02256-1. View

Omland T, Pfeffer M, Solomon S, de Lemos J, Rosjo H, Saltyte Benth J . Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease. J Am Coll Cardiol. 2013; 61(12):1240-9. DOI: 10.1016/j.jacc.2012.12.026. View

Bhatt D, Stone G, Mahaffey K, Gibson C, Steg P, Hamm C . Effect of platelet inhibition with cangrelor during PCI on ischemic events. N Engl J Med. 2013; 368(14):1303-13. DOI: 10.1056/NEJMoa1300815. View

Khan S, Dhillon O, OBrien R, Struck J, Quinn P, Morgenthaler N . C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study. Circulation. 2007; 115(16):2103-10. DOI: 10.1161/CIRCULATIONAHA.106.685503. View

10.

Yeh R, Sidney S, Chandra M, Sorel M, Selby J, Go A . Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010; 362(23):2155-65. DOI: 10.1056/NEJMoa0908610. View

11.

Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus H . High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem. 2010; 56(4):642-50. DOI: 10.1373/clinchem.2009.134460. View

12.

Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E . Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009; 361(9):868-77. DOI: 10.1056/NEJMoa0903515. View

13.

Stone G, Witzenbichler B, Guagliumi G, Peruga J, Brodie B, Dudek D . Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet. 2011; 377(9784):2193-204. DOI: 10.1016/S0140-6736(11)60764-2. View

14.

Yusuf S, Mehta S, Chrolavicius S, Afzal R, Pogue J, Granger C . Comparison of fondaparinux and enoxaparin in acute coronary syndromes. N Engl J Med. 2006; 354(14):1464-76. DOI: 10.1056/NEJMoa055443. View

15.

Gibson C, Mehran R, Bode C, Halperin J, Verheugt F, Wildgoose P . Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI. N Engl J Med. 2016; 375(25):2423-2434. DOI: 10.1056/NEJMoa1611594. View

16.

Dewilde W, Oirbans T, Verheugt F, Kelder J, de Smet B, Herrman J . Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial. Lancet. 2013; 381(9872):1107-15. DOI: 10.1016/S0140-6736(12)62177-1. View

17.

Chen Z, Pan H, Chen Y, Peto R, Collins R, Jiang L . Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet. 2005; 366(9497):1622-32. DOI: 10.1016/S0140-6736(05)67661-1. View

18.

Roffi M, Patrono C, Collet J, Mueller C, Valgimigli M, Andreotti F . 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment.... Eur Heart J. 2015; 37(3):267-315. DOI: 10.1093/eurheartj/ehv320. View

19.

Liebetrau C, Nef H, Szardien S, Dorr O, Willmer M, Voss S . Release kinetics of copeptin in patients undergoing transcoronary ablation of septal hypertrophy. Clin Chem. 2013; 59(3):566-9. DOI: 10.1373/clinchem.2012.194001. View

20.

Wallentin L, Becker R, Budaj A, Cannon C, Emanuelsson H, Held C . Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009; 361(11):1045-57. DOI: 10.1056/NEJMoa0904327. View